Apollon Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
MBI
CGI
CAM
RG
SIM
BPCE
MJRIC
RP
Apollon Wealth Management's IDXX Position: Q2 2026 in Review
Apollon Wealth Management reduced its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, selling an estimated $40.9K and leaving 5,873 shares worth $3.09M. The position accounts for 0.04% of the portfolio, ranked #395.
Apollon Wealth Management first reported a position in IDXX in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.84M in Q4 2025. 328 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Apollon Wealth Management held 5,873 shares of Idexx Laboratories worth $3.09M as of Q2 2026.
- Apollon Wealth Management sold 73 Idexx Laboratories shares in Q2 2026, an estimated $40.9K.
- Idexx Laboratories made up 0.04% of Apollon Wealth Management's portfolio in Q2 2026, its #395 holding.
- Apollon Wealth Management first reported a position in Idexx Laboratories in Q2 2021 and has held it in 21 quarters since.
- Apollon Wealth Management's Idexx Laboratories position peaked at $3.84M in Q4 2025.
- 328 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.